A Comparative Study among Intravenous Lignocaine, 2% Lignocaine Nebulisation and 4% Lignocaine Nebulisation in blunting of Laryngeal Response during Intubation, randomised clinical trial
Not Applicable
- Conditions
- Health Condition 1: R688- Other general symptoms and signs
- Registration Number
- CTRI/2021/09/036202
- Lead Sponsor
- Pondicherry Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients aged between 18 and 60 yrs.
2)American Society of Anaesthesiologists ASA 1 and ASA 2 patients coming for GA.
3)Patients coming for elective procedures.
Exclusion Criteria
1) Surgery involving the oral, nasopharyngeal, laryngotracheal airway or thyroid.
2) Patients history of respiratory disease (COPD, asthma).
3) History of recent respiratory tract infection.
4) Patients with anticipated difficult intubation and
Those requiring > 3 attempts at laryngoscopy and intubation.
5) History of any known allergy to Lignocaine.
6) Patients coming for emergency procedures.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary objective: To compare hemodynamic responses to Intubation in topical <br/ ><br>2% lignocaine and 4% lignocaine patients and compare it with intravenous lignocaine <br/ ><br> in patients undergoing General anaesthesia. <br/ ><br>Timepoint: Baseline, 1min, 2min, 3min, 4min, 5min, 10min.
- Secondary Outcome Measures
Name Time Method To study any adverse drug reactionsTimepoint: 1min, 2min, 3min, 4min, 5min, 10min